Page last updated: 2024-08-24

irinotecan and Hospital-Acquired Condition

irinotecan has been researched along with Hospital-Acquired Condition in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Limper, AH1
Crassard, N; Frappaz, D; Marec-BĂ©rard, P; Philip, T; Ranchin, B; Schell, M; Thiesse, P1

Reviews

1 review(s) available for irinotecan and Hospital-Acquired Condition

ArticleYear
Chemotherapy-induced lung disease.
    Clinics in chest medicine, 2004, Volume: 25, Issue:1

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Bleomycin; Busulfan; Camptothecin; Cyclophosphamide; Humans; Iatrogenic Disease; Interferons; Irinotecan; Lung Diseases; Methotrexate; Mitomycin; Nitrosamines; Respiratory Function Tests; Tretinoin

2004

Other Studies

1 other study(ies) available for irinotecan and Hospital-Acquired Condition

ArticleYear
Osteosarcoma metastatic to the kidney and iatrogenic hemorrhage.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Bone Neoplasms; Calcinosis; Camptothecin; Child; Combined Modality Therapy; Doxorubicin; Fatal Outcome; Female; Hematuria; Hemorrhage; Humans; Iatrogenic Disease; Ilium; Irinotecan; Kidney Neoplasms; Lung Neoplasms; Methotrexate; Osteosarcoma; Radiography; Tibia; Ultrasonography, Interventional

2008